Login / Signup

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials.

Dario GiuglianoMaria Ida MaiorinoMiriam LongoGiuseppe BellastellaPaolo ChiodiniKatherine Esposito
Published in: Endocrine (2019)
In T2D, SGLT-2i can reduce the risk of HF that is unrelated to improved glycemic control; DPP-4i and GLP-1 RAs behave as neutral.
Keyphrases
  • glycemic control
  • type diabetes
  • heart failure
  • acute heart failure
  • blood glucose
  • weight loss
  • insulin resistance
  • wild type
  • left ventricular
  • cardiac resynchronization therapy
  • metabolic syndrome